R&D Six life sciences real estate trends to watch in 2025 Evolution and innovation are critical to the field of life sciences, with each year bringing new challenges and breakthroughs.
Digital Structuring the unstructured: Deterministic AI and white box... Speed and safety in drug development and discovery represent some of the biggest challenges and opportunities facing life sciences companies today.
News Novartis snaps up PI3Kα breast cancer drug in $3bn deal Novartis has agreed to buy a PI3Kα-targeting drug for breast cancer from Synnovation, a potential successor to its Piqray brand, for $2bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
